The wait is over as Donut has finally dropped the Oshi no Ko 164 spoilers which is once again insane ... The previous chapter showed how Aqua was drowning and was in a dream where Ruby and Ai had a ...

Oshi no Ko chapter 164 arrives with the series’ climax in full effect ... who had manipulated former B-Komachi idol Fuyuko ...

While it appeared that Aqua had had enough of his father’s falsehoods and tried to die with him, would he manage to survive?

Anime character deaths evoke profound sadness and loss for viewers due to emotional connections and impactful storytelling.

The anime industry now generates a majority of its total revenue outside its home country, per The Association of Japanese Animation. With California-based companies like Crunchy Roll and Netflix ...

There are two ways to bet on the growth potential of AI. The first stock on this list ... maintain its current trajectory. Ryan Vanzo has no position in any of the stocks mentioned.

Ahead of the trip to Acrisure Stadium, Trump posted an AI-generated photo of himself in a black Steelers jersey, with pads and gloves on, wearing No. 47. When Steelers fans spotted Trump at the ...

Still, the AI summaries can be distracting, and there’s no way to deactivate them from loading, but you can click a button to filter them out. After typing something like “chocolate chip ...

AI investors should stay aware of Alphabet as ... is a member of The Motley Fool's board of directors. Will Healy has no position in any of the stocks mentioned. The Motley Fool has positions ...

If you want to create huge upside potential for your portfolio, get familiar with the AI industry. According to data compiled by Statista, the AI market is already worth $184 billion. But by the ...

The company is investing in enhancing the AI capabilities of its MicroStrategy ONE analytics platform. In 2023, the company expanded a multiyear partnership with Microsoft to integrate ...

Oshi Health, a telehealth provider that treats gastrointestinal conditions such as irritable bowel syndrome and colitis, said last week that it raised a $60 million Series C funding round.